We demonstrate that endogenously produced PGD2 is responsible for cytokine-induced ILC2 activation and that CRTH2 antagonism is a powerful therapeutic approach in allergic inflammation as it prevents not only PGD2-induced, but also indirectly cytokine-induced ILC2 activation. (Source: Journal of Allergy and Clinical Immunology)
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader http://bit.ly/2QKSo7U
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.